Skip to content
Search
Search
Quick Exit
About
About Inquiries
About the Lampard Inquiry
Scope of the Lampard Inquiry
Final Terms of Reference
Explanatory Note on Scope
List of Issues
Inquiry Team
Terminology and Glossary
Financial Report
FAQs
General FAQs
Terms of Reference FAQs
Hearings FAQS
Evidence FAQS
Core Participant and Witness FAQs
Policies and Protocols
Protocol on Core Participants
Hearings Protocols
Protocol for the April Hearing
Protocol on the Questioning of Witnesses in Oral Hearings under Rule 10 of the Inquiry Rules 2006
Witnesses Protocols
Compelling Witnesses
Protocol on Witness Statements
Protocol on Vulnerable Witnesses
Protocol on Whistleblowing
Anonymity and Restriction Orders
Patient Identity Restriction Orders
Patient Anonymity
Restriction Orders
Protocol on Restriction Orders
Costs protocols
Protocol on Legal Costs
Protocol on Witness Expenses
Protocol on Applications for
Core Participant Legal Funding
Notice of Determination
Information Handling
Statement of approach: Redaction, Data Protection and Privacy
Protocol on Documents
Privacy Information Notice
Prohibition on the destruction
of documents
Lampard Inquiry Disclosure Update – March 2025
Appropriate Policy Document
Protocol on the Role and Appointment of Assessors
Protocol on the Role and Instruction of Experts
Protocol on Equality, Diversity
and Inclusion
Lived Experience Framework
Protocol on Rule 13 Warning Letters and the Opportunity to Respond Process [‘OTR’]
Statement of Approach
Statement of Approach – Investigating illustrative cases
Statement of Approach to Investigating Sexual Safety
Hearings
Hearings
Logistical Information
Hearings FAQS
Statement of Approach – Investigating Illustrative Cases
Evidence and Reports
Evidence Overview
Opening Statements
Hearing Evidence Bundles
Bereaved Families & Friends – Evidence
Background Presentations to Inquiry Hearings
Paper on Public Inquiry Recommendations
Evidence FAQS
Participants and Witnesses
Core Participants
Statement of Approach
How to Apply
List of Core Participants
Compelling Witnesses
Core Participant and Witness FAQs
Bereaved Families and Friends FAQs
Open Letter from Chair to bereaved families (April 2026)
Staff Witnesses FAQs
Support
Emotional support provided by the Inquiry
Support Services
Safeguarding
Contact
Updates
About
About Inquiries
About the Lampard Inquiry
Scope of the Lampard Inquiry
Final Terms of Reference
Explanatory Note on Scope
List of Issues
Inquiry Team
Terminology and Glossary
Financial Report
FAQs
General FAQs
Terms of Reference FAQs
Hearings FAQS
Evidence FAQS
Core Participant and Witness FAQs
Policies and Protocols
Protocol on Core Participants
Hearings Protocols
Protocol for the April Hearing
Protocol on the Questioning of Witnesses in Oral Hearings under Rule 10 of the Inquiry Rules 2006
Witnesses Protocols
Compelling Witnesses
Protocol on Witness Statements
Protocol on Vulnerable Witnesses
Protocol on Whistleblowing
Anonymity and Restriction Orders
Patient Identity Restriction Orders
Patient Anonymity
Restriction Orders
Protocol on Restriction Orders
Costs protocols
Protocol on Legal Costs
Protocol on Witness Expenses
Protocol on Applications for
Core Participant Legal Funding
Notice of Determination
Information Handling
Statement of approach: Redaction, Data Protection and Privacy
Protocol on Documents
Privacy Information Notice
Prohibition on the destruction
of documents
Lampard Inquiry Disclosure Update – March 2025
Appropriate Policy Document
Protocol on the Role and Appointment of Assessors
Protocol on the Role and Instruction of Experts
Protocol on Equality, Diversity
and Inclusion
Lived Experience Framework
Protocol on Rule 13 Warning Letters and the Opportunity to Respond Process [‘OTR’]
Statement of Approach
Statement of Approach – Investigating illustrative cases
Statement of Approach to Investigating Sexual Safety
Hearings
Hearings
Logistical Information
Hearings FAQS
Statement of Approach – Investigating Illustrative Cases
Evidence and Reports
Evidence Overview
Opening Statements
Hearing Evidence Bundles
Bereaved Families & Friends – Evidence
Background Presentations to Inquiry Hearings
Paper on Public Inquiry Recommendations
Evidence FAQS
Participants and Witnesses
Core Participants
Statement of Approach
How to Apply
List of Core Participants
Compelling Witnesses
Core Participant and Witness FAQs
Bereaved Families and Friends FAQs
Open Letter from Chair to bereaved families (April 2026)
Staff Witnesses FAQs
Support
Emotional support provided by the Inquiry
Support Services
Safeguarding
Contact
Updates
Quick Exit
Home
Evidence
Hearing Day 54 – Evidence
Hearing Day 54 – Evidence
Evidence Information
Submission date:
21st Jul 2026
Hearing:
Hearing Day 54 – July Hearing (2026)
Submission date:
21st Jul 2026
Available Documents (40)
Filter evidence
FINAL Oxevision Comparator Trust Evidence Paper - 10 July 2026
(pdf: 172.02 KB)
TEWV021312_BM9-Oxevision-poster-at-TEWV
(pdf: 925.42 KB)
TEWV021319_BM22-Oxehealth-Stopped-Rooms-Report-ReTEWV
(pdf: 14.88 MB)
TEWV021320_BM21-TEWV-Privacy-Notice
(pdf: 20.96 MB)
TEWV021322_BM17 Data Protection Impact Assessment - for Sleep Module
(pdf: 29.07 MB)
TEWV021323_BM2 TEWV Oxevision Poster
(pdf: 914.38 KB)
TEWV021324_BM19 TEWV Service Level Agreement with Oxehealth
(pdf: 3.16 MB)
TEWV021325_BM16 TEWV Data Protection Impact Assessment (DPIA) for Oxevision
(pdf: 75.84 MB)
TEWV021327_BM15 TEWV Terms of Reference for the Trust’s Oxehealth Governance Group
(pdf: 8.19 MB)
TEWV021328_BM11 TEWV Oxevision Benefits Realisation Results
(pdf: 24.36 MB)
TEWV021331 - Exhibit BM1 - Spreadsheet - Wards and implementation dates
(xlsx: 25.17 KB)
TEWV024264_Witness Statement of Beverley Murphy
(pdf: 2.89 MB)
TEWV021330_BM10 TEWV Report_ Re Oxehealth _Digital Care Assistant_ trial-to-scale
(pdf: 8.83 MB)
TEWV021329_BM14 TEWV Service Evaluation Report of Staff_ Patients and Carers experiences of Oxevision use
(pdf: 28.12 MB)
TEWV021317_BM3 TEWV Leaflet detailing Oxevision use
(pdf: 3.3 MB)
TEWV021316_BM6 TEWV Oxehealth Policy
(pdf: 46.76 MB)
TEWV021314_BM8 TEWV Leaflets detailing Oxevision use_ given to patients on admission
(pdf: 8.72 MB)
TEWV021313_BM7 TEWV Oxehealth Procedure
(pdf: 76.71 MB)
TEWV024265_BM13 TEWV Quantitative impact of Oxevision
(pdf: 13.28 MB)
TEWV021332_BM12 TEWV Early Insights Report containing early insights into use of Oxevision
(pdf: 16.51 MB)
TEWV025661_First Witness Statement of Elspeth Devanney_ Director of Nursing _ Quality_ Tees Esk
(pdf: 257.33 KB)
LPT022553_NP10 LPT Oxevision Ashby Ward Pilot Cost Benefit Analysis
(pdf: 2.94 MB)
LPT022556_NP06a Oxehealth Weekly Usage Report Re LPT
(pdf: 4.29 MB)
LPT022545_NP11 LPT Business Case for Oxevision
(pdf: 17.84 MB)
LPT022555_NP08 LPT Board Meeting Paper_ Re Oxehealth - Learning from contract
(pdf: 9.87 MB)
LPT022562_NP03 LPT Standard Operating Procedure for the use of Oxevision Acute Wards - Ashby Pil
(pdf: 30.8 MB)
LPT022563_NP01a LPT Oxevision Patient Poster
(pdf: 3.29 MB)
LPT023355_Witness Statement of Andres Freire-Patino
(pdf: 2.68 MB)
LPT022550_NP06e LPT Oxehealth Stopped rooms report
(pdf: 3.61 MB)
LPT022551_NP07 LPT OxeVision Patient Consent Form
(pdf: 1 MB)
LPT022552_NP09 LPT Oxevision - Ashby Ward Pilot Evaluation Report
(pdf: 16.49 MB)
LPT022557_NP06d Oxehealth Weekly Usage Report Re LPT
(pdf: 4.32 MB)
LPT022558_NP06b Oxehealth Weekly Usage Report Re LPT
(pdf: 4.31 MB)
LPT022559_NP06c Oxehealth Weekly Usage Report Re LPT
(pdf: 4.3 MB)
LPT022560_NP05 LPT DPIA template
(pdf: 13.61 MB)
LPT022561_NP04 LPT Oxevison Pilot Quick Reference Guide
(pdf: 5.97 MB)
LPT022564_NP02 LPT Easy Read Oxevision Poster
(pdf: 2.62 MB)
LPT022565_NP01b LPT Oxevision Leaflet
(pdf: 1.46 MB)
TEWV021315_BM4 TEWV Oxevision Leaflets detailing information provided to the patients on admission
(pdf: 3.42 MB)
TEWV021321_BM20 Oxevision Monthly Usage Report June -December 2024
(pdf: 15.33 MB)
Related hearings
Hearing Day 54 – July Hearing (2026)
Hearing type:
Public Hearing
21st Jul 2026
View Hearing
Other Evidence
Hearing Day 56 Evidence
Evidence Information
Hearing:
Hearing Day 54 – July Hearing (2026)
search evidence
Search evidence
View advanced filters
Evidence submission dates
2026 (select all)
View by month
Jul 2026 (select all)
View by day
21 Jul 2026
09 Jul 2026
08 Jul 2026
07 Jul 2026
06 Jul 2026
Feb 2026 (select all)
View by day
16 Feb 2026
11 Feb 2026
10 Feb 2026
09 Feb 2026
04 Feb 2026
03 Feb 2026
02 Feb 2026
2025 (select all)
View by month
Dec 2025 (select all)
View by day
08 Dec 2025
Oct 2025 (select all)
View by day
27 Oct 2025
23 Oct 2025
22 Oct 2025
21 Oct 2025
20 Oct 2025
16 Oct 2025
15 Oct 2025
14 Oct 2025
13 Oct 2025
Jul 2025 (select all)
View by day
14 Jul 2025
10 Jul 2025
09 Jul 2025
08 Jul 2025
07 Jul 2025
May 2025 (select all)
View by day
15 May 2025
13 May 2025
12 May 2025
08 May 2025
06 May 2025
01 May 2025
Apr 2025 (select all)
View by day
30 Apr 2025
29 Apr 2025
28 Apr 2025
1999 (select all)
View by month
Dec 1999 (select all)
View by day
30 Nov 1999
Quick Exit
About
About Inquiries
About the Lampard Inquiry
Scope of the Lampard Inquiry
Final Terms of Reference
Explanatory Note on Scope
List of Issues
Inquiry Team
Terminology and Glossary
Financial Report
FAQs
General FAQs
Terms of Reference FAQs
Hearings FAQS
Evidence FAQS
Core Participant and Witness FAQs
Policies and Protocols
Protocol on Core Participants
Hearings Protocols
Protocol for the April Hearing
Protocol on the Questioning of Witnesses in Oral Hearings under Rule 10 of the Inquiry Rules 2006
Witnesses Protocols
Compelling Witnesses
Protocol on Witness Statements
Protocol on Vulnerable Witnesses
Protocol on Whistleblowing
Anonymity and Restriction Orders
Patient Identity Restriction Orders
Patient Anonymity
Restriction Orders
Protocol on Restriction Orders
Costs protocols
Protocol on Legal Costs
Protocol on Witness Expenses
Protocol on Applications for
Core Participant Legal Funding
Notice of Determination
Information Handling
Statement of approach: Redaction, Data Protection and Privacy
Protocol on Documents
Privacy Information Notice
Prohibition on the destruction
of documents
Lampard Inquiry Disclosure Update – March 2025
Appropriate Policy Document
Protocol on the Role and Appointment of Assessors
Protocol on the Role and Instruction of Experts
Protocol on Equality, Diversity
and Inclusion
Lived Experience Framework
Protocol on Rule 13 Warning Letters and the Opportunity to Respond Process [‘OTR’]
Statement of Approach
Statement of Approach – Investigating illustrative cases
Statement of Approach to Investigating Sexual Safety
Hearings
Hearings
Logistical Information
Hearings FAQS
Statement of Approach – Investigating Illustrative Cases
Evidence and Reports
Evidence Overview
Opening Statements
Hearing Evidence Bundles
Bereaved Families & Friends – Evidence
Background Presentations to Inquiry Hearings
Paper on Public Inquiry Recommendations
Evidence FAQS
Participants and Witnesses
Core Participants
Statement of Approach
How to Apply
List of Core Participants
Compelling Witnesses
Core Participant and Witness FAQs
Bereaved Families and Friends FAQs
Open Letter from Chair to bereaved families (April 2026)
Staff Witnesses FAQs
Support
Emotional support provided by the Inquiry
Support Services
Safeguarding
Contact
Updates